Stay updated on Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma

Sign up to get notified when there's something new on the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.3.3 appears in the history. The HHS Vulnerability Disclosure link and Revision: v3.3.2 have been removed.
    Difference
    0.2%
    Check dated 2025-12-22T01:46:12.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    A new Revision: v3.3.2 was added to the record history; the previous Revision: v3.3.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-30T16:14:07.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision history shows a new version, v3.3.1, replacing the previous v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-23T14:47:03.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The funding-lapse notice text was removed from the page.
    Difference
    0.8%
    Check dated 2025-11-16T14:16:03.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Version 2 (2022-04-27) adds changes to Recruitment Status, Study Status, and Study Design in the record history. These updates reflect a shift in the trial's current enrollment and design information.
    Difference
    0.1%
    Check dated 2025-11-02T00:46:12.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Introducing a major status and governance notice plus a version upgrade to v3.2.0; old v3.1.0 tag removed. The core page now informs users about funding-related limitations and where to check operating status.
    Difference
    13%
    Check dated 2025-10-04T12:22:45.000Z thumbnail image

Stay in the know with updates to Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page.